UB-621 high-dose for herpes genitalis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 28 Jul 2021: Trial registered, NCT04979975

The trials

NCT04979975: Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes

State
Not started
Phase
Phase 2
People
200 planned
Started
Dec 2023
Primary completion
Dec 2025
Arms
UB-621 high-dose
Results
None posted
  1. 28 Jul 2021: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.